Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome (CAPITAIN)

This study has been completed.
Information provided by (Responsible Party):
Kowa Research Europe Identifier:
First received: May 2, 2012
Last updated: July 19, 2013
Last verified: July 2013